Patients' views about taking a polypill to manage cardiovascular risk: a qualitative study in primary care.
British Journal of General Practice, June 2015
Virdee, Satnam K, Greenfield, Sheila M, Fletcher, Kate, McManus, Richard J, Mant, Jonathan
A 'polypill' containing a combination of antihypertensives and statins could prevent up to 80% of cardiovascular disease (CVD) events. To investigate patients' opinions about the use of a polypill for CVD prevention. Qualitative study of 17 patients from seven primary care practices in Birmingham, UK. Patients were recruited through purposive sampling to maximise variation of characteristics. Semi-structured interviews were conducted with responders. Results were analysed and reported using a qualitative description approach. Patients expressed concerns that polypill prescription for primary prevention simply on the basis of age was unnecessary and would lead to side effects, despite recognising potential benefits. For high-risk patients, or for secondary prevention, a polypill was deemed more acceptable, but was still felt to require regular monitoring of blood pressure and cholesterol. Patients were sceptical about the role of a polypill as a 'blanket' approach. If a population strategy offering a polypill to all people over a certain age was to be implemented, it would need to be supported by patient education.
|Readers by professional status||Count||As %|
|Student > Master||6||30%|
|Student > Bachelor||3||15%|
|Student > Doctoral Student||3||15%|
|Student > Ph. D. Student||2||10%|
|Readers by discipline||Count||As %|
|Medicine and Dentistry||7||35%|
|Agricultural and Biological Sciences||4||20%|
|Nursing and Health Professions||2||10%|
|Pharmacology, Toxicology and Pharmaceutical Science||2||10%|